Glycosphingolipids serve as ligands for receptors involved in signal transduction and immune recognition, as exemplified by isoglobotrihexosylceramide, an antigenic ligand for T cell receptors. Mechanistic studies on the regulation of isoglobotrihexosylceramide require biochemical measurement of its lysosomal precursor, isoglobotetraglycosylceramide. It remains a challenge to distinguish between complex tetraglycosylceramide glycosphingolipid isomers with the same sugar components but diverse internal linkages. Here we established a simple and sensitive method to separate globo-and isoglobotetraglycosylceramide by MS 5 ion trap mass spectrometry, and report the identification of isoglobotetraglycosylceramide in a CHO cell line transfected by iGb 3 synthase, as well as in human thymus.
Introduction
The role of glycoconjugates in cell signaling has emerged from the combined effort of biologists, analytical chemists and synthetic chemists (Zhou 2006a (Zhou , 2006b ). The concept that glycans are ligands for biological receptors underlies current functional glycomics research initiatives. In contrast to protein or nucleotide ligands, the creation of glycan ligands depends on an "assembly line" (Kornfeld R and Kornfeld S 1985) , i.e., it requires multiple enzymes for stepwise assembly. The regulation of glycan ligands is dependent not only on the transcriptional regulation of multiple glyco-enzymes, but also on the interaction of these glyco-enzymes with chaperone or activator proteins in different intracellular compartments, and the availability of substrates for glyco-enzymes. Thus, the regulation of expression of a specific glycan ligand is much more complex than that of proteins and nucleotides.
Such glycans serving as biological ligands include the glycosphingolipid (GSL) recognized by natural killer T (NKT) cells. NKT cells are a subset of innate-like T cells that carry the surface markers of both T cells and NK cells (Kronenberg and Gapin 2002; Taniguchi et al. 2003; Pear et al. 2004; Bendelac et al. 2007 ). NKT cells express very restricted, evolutionarily conserved, and germ-line-encoded T cell receptors (TCRs), as compared to the extremely diverse, recombined TCRs expressed by conventional T cells. In contrast to conventional T cells which recognize peptide antigens presented by MHC molecules, NKT cells recognize glycolipid antigens presented by a non-MHC-encoded, nonpolymorphic, MHC-like antigenpresenting molecule, CD1d. The activation of NKT cells is strictly dependent on TCR stimulation, but is inordinately rapid, leading to cytokine secretion within 2 h. Thus, like NK cells, NKT cells play critical "jump starting" functions in antimicrobial and antitumor immunity, through mechanisms that are only partially understood. NKT cells activate the professional antigen-presenting cells (dendritic cells) to enhance their function of antigen presentation. The molecular interaction between NKT cells and dendritic cells remains partially understood. It has been demonstrated that TCR recognition of glycolipid antigens presented by CD1d in dendritic cells is essential for initiating the crosstalk between NKT cells and dendritic cells. For example, in a study on tumor progression in mice, NKT cells interacted with dendritic cells in the tumor microenvironment, and the activation of NKT cells by tumor-derived ligands promoted the activation of adaptive immune response (CD4 and CD8 responses), which caused rejection of tumor (Smyth et al. 2000) . In another study, NKT cells were activated by dendritic cell-derived glycolipid antigens, and protected the mice from bacteria infection (Mattner et al. 2005) .
The identities of endogenous NKT ligands have been an enigma for more than a decade. Genetic evidence suggested that these ligands are GSLs derived from glucosylceramide (Stanic et al. 2003) . Zhou et al. first identified a neutral GSL, isoglobotriosylceramde (iGb 3 ), as a natural ligand (Zhou et al. 2004; Zhou 2006b ). This finding was confirmed by multiple independent studies showing that iGb 3 stimulated a variety of mouse and human NKT clones representing a majority of invariant NKT population Xia et al. 2006; ScottBrowne et al. 2007; Yu et al. 2007 ). These include human NKT cell lines, mouse hybridomas generated in different laboratories and, more recently TCR-transfected lines (Behar et al. 1999; Gui et al. 2001; Scott-Browne et al. 2007 ). These results encouraged us to study the biochemistry of isoglobo series of GSLs in immune organs and immune cells. In view of the low abundance of T cell antigens in antigen-presenting cells, we have explored the application of ion trap mass spectrometry (MS n ) technology to the analysis of complex mixtures of cellular GSLs. The principle of this method is that signature ion fragments can be generated for each specific GSL after multiple rounds of fragmentation, which allows the identification of NKT antigens such as iGb 3 by mass spectrometry without purifying individual glycolipids, even in the presence of large quantity of regioisomers Lapadula et al. 2005; Zhang et al. 2005; Li et al. 2007 ). Here, we extended this approach to study the regioisomers iGb 4 and Gb 4 , since iGb 3 is generated in the lysosome through cleavage of iGb 4 by β-hexosamindases. This new method should enhance the study of the assembly line leading to the expression of iGb 3 in antigen-presenting cells. As a first step for future studies on the regulation of these biologically important GSLs, we report here the presence of iGb 4 in human thymus.
Results

Discrimination of iGb 4 from Gb 4 by permethylation and multistep ion trap MS n
Previous studies showed that the terminal Galα3Gal-1-ene disaccharide from the sodium adduct of permethylated isoglobotrihexosylceramide (iGb 3 , Galα3Galß4Glcβ1Cer) produces an ion trap MS 4 spectrum readily distinguishable from that of the terminal Galα4Gal-1-ene disaccharide of similarly treated and analyzed globotrihexosylceramide (Gb 3 , Galα4Galß4Glcβ1Cer) Lapadula et al. 2005; Zhang et al. 2005; and Li et al. 2007 ). Since these trihexosylceramides are often observed as internal sequences in further glycosylated products, such as Gb 4 and iGb 4 , an essential question is whether the internal Galα3/4Gal disaccharides could be isolated and discriminated by an analogous method. Compared with the nonreducing terminal disaccharides of Gb 3 /iGb 3 , one additional fragmentation step is required to generate the required internal HO-3Galα3/4Gal-1-ene precursor m/z 431. When this was fragmented in MS 5 , product ions were indeed observed which appeared to be diagnostic for iGb 4 versus Gb 4 (Scheme 1).
Shown in Figure 1 /z 199, 225, 243, 329, and 401 . These are consistent with specific glycosidic and cross-ring cleavages, along with typical neutral losses, as shown in Scheme 1. It is notable that several ions in the m/z 431 product spectrum from iGb 4 , including the highly abundant fragment m/z 357, are virtually absent in the corresponding spectrum from Gb 4 . Conversely, the most abundant ion in the m/z 431 product spectrum from Gb 4 , m/z 315, is barely observable above noise in the corresponding spectrum from iGb 4 . These can be proposed, therefore, to form the basis for discriminating the internal Galα3/4Gal linkage in binary mixtures containing isobaric Gb 4 /iGb 4 molecular species. 
Detection of iGb 4 /Gb 4 tetraglycosylceramides in CHO cells transfected by iGb 3 synthase enzyme
To test the applicability of our method to detect iGb 4 in biological samples, we analyzed a CHO cell line transfected by rat iGb 3 synthase enzyme (Teneberg et al., in preparation) , designated as CHO-iGb 3 cells here. The CHO cell line was transfected by a mock pcDNA3.1-Hygro+ plasmid was used as a negative control, designated as CHO cells here. Neutral GSL mixtures from CHO-iGb 3 and CHO cells were permethylated and analyzed by electrospray ionization linear ion trap MS (ESI-LIT-MS) as described above.
Matching sections (m/z 1540 to 1610) of ESI-LIT-MS 1 profile spectra of permethylated neutral GSL fractions isolated from CHO-iGb 3 and CHO cells are shown in Figure 2 The 90-100% abundance of MS 5 signature ions for iGb 3 , in combination with a significant increase of total iGb 4 /Gb 4 molecular ions in CHO-iGb 3 as compared with CHO in the MS 1 spectrum, suggest that the majority of the tetraglycosylceramide fraction in CHO-iGb 3 cells is iGb 4 .
Detection of iGb 4 and Gb 4 in a mixture of tetraglycosylceramides isolated from human thymus
We next used our method to measure iGb 4 in tetraglycosylceramides purified from pooled thymi from human pediatric patients. In this case, we first used an instrumental "precursor ion mapping" routine to identify all molecular adduct ions, observable in MS 1 , that generate m/z 912 in MS 2 (Figure 3 , left panel). By this method we are confident that we are not missing any MS 1 ion that may represent a mixture of iGb 4 /Gb 4 .
Combining precursor ion mapping with multistep ion trap MS n analysis, a series of isobaric mixtures of Gb 4 and iGb 4 were detected in the tetraglycosylceramide fraction isolated from human thymus. We found that the MS 5 product ion m/z 357 was reliably observed as a signature of iGb 4 in MS 5 spectra of all Table I lists the parent  ion profiles and results of MS  5 analysis. An extremely heterogeneous mixture of iGb 4 /Gb 4 isobars was found for human thymic tetraglycosylceramides. This is ascribed to different length and functionalization of both the fatty acid chains and sphingoids.
Discussion
Here we present a first demonstration of the presence of iGb 4 in human thymus. In combination with our previous finding that iGb 3 is a minor component of human thymic trihexosylceramide (Teneberg et al., in preparation) , the results demonstrate that the isoglobo series of GSLs are expressed in human thymus.
Our data contradict a popular hypothesis that human do not express iGb 3 (Milland et al. 2005; Milland et al. 2006; Sandrin 2007; Speak et al. 2007 ). This notion stems from the belief that iGb 3 would bind to anti-α-Gal antibodies, which are naturally expressed in humans and, together with the Galα3Galβ4GlcNAc epitope, would cause hyper acute rejection in xeno-transplantation. Human natural anti-α-Gal antibodies could bind to synthetic Galα3Galβ4Glc glycan conjugated to BSA in an ELISA assay (Andreana et al. 2004 ). However, they did not bind to intact iGb 3 glycolipid in a TLC-immunoblot, as we previously reported (Teneberg et al. 1996; Zhou et al. 2004) . Consistent with our finding, later studies found that organs from α3GalT1 knockout pigs lacking the Galα3Galβ4GlcNAc epitope did not cause hyper acute rejection (Yamada et al. 2005) . Nevertheless, it has been suggested that iGb 3 expressed in the xenograft would activate NKT cells and ultimately promote rejection (Sandrin 2007 ). This hypothesis was supported by the failure to detect iGb 3 in human tissue sections by immunohistochemistry (Milland et al. 2006) , which implied that humans would see and respond to iGb 3 as a foreign antigen. It was also suggested that human iGb 3 synthase is a pseudogene based on negative finding by reverse-transcription-PCR (RT-PCR) experiments (Milland et al. 2006; Speak et al. 2007 ). In contrast, we have found the presence of mRNA transcripts for iGb 3 synthase in human thymus, and have cloned a full-length cDNA (unpublished data). The detailed enzymatic basis for isoglobo series GSLs in human and in mouse, as well as their regulation, is currently being investigated.
Another group reported the failure to detect iGb 3 and iGb 4 in human tissues, using an HPLC method assaying fluorescencelabeled glycans cleaved from ceramides (Speak et al. 2007 ). The same method did not detect iGb 3 and iGb 4 in the mouse thymus either. Using a similar ion trap MS n -based method as reported here, we demonstrated the presence of iGb 3 in both human and mouse thymus (Teneberg et al., in preparation) . The discrepancy between these reports may be due to the sensitivity of the different methods. We found that thymic trihexosylceramides (iGb 3 and Gb 3 ) were very heterogeneous with respect to their fatty acid components, and overall iGb 3 represented a minor fraction of the trihexosylceramides. Speak et al. reported that their HPLC method could detect as little as 1% of iGb 3 in an iGb 3 /Gb 3 mixture (Speak et al. 2007 ). According to our ion trap MS n assay, which distinguishes between trihexosylceramide species that differ by their fatty acid components, many trihexosylceramide species contained less than 1% iGb 3 , suggesting an explanation for the failure of Speak et al. to detect it.
We have successfully established a method to detect iGb 4 in biological samples, by comparing the signature MS 5 ion fragments to those of the standard iGb 4 . The selectivity of our method is based on exploiting the ability of the ion trap to (i) specifically isolate the internal HO-3Galα3/4Gal-1-ene disaccharide fragment, containing the iGb 4 /Gb 4 structure-defining isomeric linkages, from each molecular precursor whose m/z and intermediate fragments are consistent with the correct glycan formula and sequence; and (ii) fragment this disaccharide in an additional CID-MS step to yield product ions that distinguish the two linkages, including cross-ring cleavage fragments and further products which are linkage specific . Differences in relative abundances of some common fragments can provide additional criteria for confirming the target linkages or ruling out others. Significantly, the method is capable of detecting one isomer in the presence of the other, even where the latter occurs at far higher levels. Where very low levels of GSLs are being analyzed, a precursor ion mapping routine can help to locate candidate molecular ions, even in noisy profile spectra. This was facilitated by the low sample consumption of the nanoelectrospray source. Although precursor ion scanning, as carried out on a tandem MS/CID-MS instrument, is a more efficient and sensitive process for this purpose, tandem instruments cannot perform the required number of fragmentation steps (MS 5 in this case) to isolate specific disaccharides and produce linkage-specific fragments from them. A hybrid tandem configuration, such as in a QqLIT/Q instrument, for example, could provide efficient implementation of all the necessary capabilities for higher throughput analysis, if sufficient sensitivity can be maintained.
A further step of development would be to establish a quantitative approach, e.g., by mixing our samples with a known amount of a suitably distinct iGb 4 internal standard. These approaches, combined with our methods to measure other intermediate metabolites of the isoglobo series of GSLs (lactosylceramide and glucosylceramide), may help to understand the metabolism of iGb 3 , which remains the only well-established natural ligand of NKT cells as confirmed by independent laboratories. The ion trap MS n technology described here therefore represents a powerful, generally applicable method for the analysis of other biologically active GSLs, as well as their metabolic pathways.
Materials and methods
Tissues and cultured cells
Human thymi from pediatric patients (aged between 1 month to 5 years old) undergoing open-heart surgery were collected and pooled. All human samples were collected under institutionally approved protocols at University of Chicago Hospitals or the University of Texas M.D. Anderson Cancer Center at Houston. The CHO cells and CHO-iGb 3 cells have been cultured and harvested as described (Teneberg et al., in preparation) , and stored in 16 × 100 mm glass tubes at −80
• C.
Per-N,O-methylation of neutral GSLs
A modification of the method of Ciukanu and Kerek (Ciucanu and Kerek 1984; Ciucanu and Costello 2003) was employed for per-N,O-methylation of GSLs. GSLs (1-20 µg) were introduced into a conical glass vial, and dimethyl sulfoxide (150 µL) was added without using special drying conditions or inert gas atmosphere. Powdered sodium hydroxide (40-60 mg) was then added to the sample solution, and was stirred at room temperature until completely dissolved. Iodomethane (80 µL) was added with a syringe, and the mixture was shaked at room temperature for 1 h. The methylation reaction was quenched with water (2 mL). The permethylated products were extracted three times by addition of dichloromethane (2 mL). The combined dichloromethane extracts were then washed three times with water (2 mL each). Following the final wash, the samples were transferred to a new tube, and dried under nitrogen stream at 35-40
Electrospray ionization linear ion trap mass spectrometry (ESI-LIT-MS n ) of permethylated neutral GSLs Electrospray ionization mass spectrometry (MS and MS
n ) was carried out in positive ion mode on a linear ion trap mass spectrometer (LTQ, ThermoFinnigan, San Jose, CA), using a nanoelectrospray source, with a flow rate of 0.30 µL/min and at capillary temperature 230
• C with injection time 100.00 ms, activation time 30 ms, activation Q-value 0.250, isolation width m/z 1.5, and acquisition time 3 min. Normalized collision energies were set to leave a minimal residual abundance of precursor ion; in this case, 30% was used for all product ion scans. All ions were detected as sodium adducts. To obtain MS 5 spectra specifically from the characteristic internal HO-3Galα3/4Gal-1-ene disaccharides, each iGb 4 /Gb 4 molecular species (or lipoform, observed at, e.g., m/z X), was subjected to multistep fragmentation via the MS 5 pathway X→912→690→431→ (corresponding to Scheme 1).
Mapping of precursors of the m/z 912 (912.5) MS 2 fragment was performed with a standard subroutine in the ThermoFinnigan Xcalibur software package, using the following parameters: scan filter MS 2 ; activation type, CID; precursor m/z range 1450.0-1650.0, precursor ion step m/z 0.2, isolation width m/z 2.0 Th, product m/z 912.5, normalized collision energy 35%, activation Q-value 0.250, activation time 30 ms, and total run time 100 min. Profiles of iGb 4 /Gb 4 molecular adduct ions were obtained as a "map" of all precursors yielding the MS 2 ion at m/z 912.5 (see Figure 3) . Each precursor of m/z 912.5 observed in significant abundance (m/z X) was then subjected to MS 5 analysis by the X→912→690→431→ pathway as described above.
Isobaric iGb 4 and Gb 4 reference standards
Purified isobaric iGb 4 and Gb 4 (C 70 H 130 N 2 O 23 , MW 1366; permethylated MW 1548) were obtained from nonacid GSL fractions by standard procedures as previously described (Teneberg et al. 1996) . The individual GSLs were isolated by repeated chromatography of native or acetylated fractions on silicic acid columns and by HPLC. They were stored in chloroformmethanol 1:1 (v/v), and further diluted to obtain standards of concentration as indicated. Both of them (5 µg each) were permethylated and subjected to ESI-LIT-MS n analysis as described above.
Total lipid extraction from CHO cells
Lipids were extracted by extensive sonication four times with mixed polarity solvents. The first and last solvent used was chloroform-methanol 1:1 (v/v). The second and third solvent used was isopropanol-hexane-water 55:25:20 (v/v/v, upper phase removed by aspiration before use). Sonication was followed by centrifugation to pellet the insoluble material. The supernatants were pooled and dried under nitrogen stream at 40
• C, and subjected to preliminary analysis by high-performance thin layer chromatography (HPTLC).
Separation of neutral and acidic lipids from CHO cells
Neutral and acidic lipids were fractionated by anion exchange chromatography on a small column of DEAE Sephadex A-25 (Yu and Ledeen 1972) in chloroform-methanol-water 30:60:8 (v/v/v) ; neutral lipids were eluted with five column volumes of this solvent, while the acidic lipid fraction was eluted with 0.8 M sodium acetate in methanol. Both neutral and acidic fraction were dried, desalted by dialysis, dried by rotary evaporation, and analyzed by HPTLC.
Florisil fractionation of neutral GSLs from CHO cells
The method of Saito and Hakomori (1971) was employed for removing non-GSL impurities from the neutral GSL fraction. The DEAE Sephadex A-25 pass-through fraction was dried under vacuum in the presence of P 2 O 5 for 3 h and peracetylated with 4 mL pyridine and 2 mL acetic anhydride in the dark at room temperature overnight. The peracetylated material was dried by rotary evaporation, with the addition of 2 mL toluene for three times to ensure complete evaporation. A Florisil column (30-60 mesh, 10 × 80 mm) was equilibrated in 1,2-dichloroethane-hexane 4:1 (v/v). The peracetylated sample was applied in this solvent, and the column was then washed with 100 mL of the same solvent, followed by 100 mL 1,2-dichloroethane. Neutral peracetylated GSLs were eluted with 200 mL 1,2-dichloroethane-acetone 1:1 (v/v). The fractions were dried by rotary evaporation and deacetylated with 5 mL 0.5 M sodium methoxide in 10 mL methanol for 3 h at room temperature. The mixture was neutralized with methanolic acetic acid, dried by rotary evaporation, and then desalted by dialysis. The GSL contents of all three fractions were compared by HPTLC; GSLs were always observed to be in the third fraction.
Detection of iGb 4 /Gb 4 tetraglycosylceramides in CHO cells and CHO transfected by iGb 3 synthase
Neutral GSLs from CHO cells and CHO-iGb 3 cells, isolated by Florisil column were permethylated and subjected to ESI-LIT-MS n analysis as described above. The presence of iGb 4 /Gb 4 was confirmed separately in each lipoform by the analysis of MS 5 product ion spectra from each precursor as described above (i.e., X→912→690→431→), and relative amounts of them were determined by comparing the different ion abundance of each identified molecular species in the two kinds of CHO cells represented in the MS 1 profile spectrum. MS 2 spectra were systematically acquired for every molecular precursor ion m/z 912 in the MS 1 spectrum from m/z 1450 to 1650 (covering the range of tetraglycosylceramides with ceramide compositions having d18:1, d18:0, or t18:0 sphingoids N-acylated with C16 to C28 fatty acid).
